Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04557618 · ClinicalTrials.gov registry record · NA

Auricular VNS Following Subarachnoid Hemorrhage

A NA study of Subarachnoid Hemorrhage, sponsored by Anna Huguenard.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04557618 is a NA study of Subarachnoid Hemorrhage that is actively recruiting participants, run by Anna Huguenard. The registered enrollment target is 50 participants, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04557618, a NA study of Subarachnoid Hemorrhage, is actively recruiting participants, sponsored by Anna Huguenard.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.

Conditions Studied

Interventions

  • DEVICE Auricular Vagus Nerve Stimulation
  • DEVICE Sham Auricular Vagus nerve Stimulation

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-01-05
Est. Completion 2028-12
Phase NA

Sponsor

Anna Huguenard

1 total trials

What the Registry Record Tells You About NCT04557618

The ClinicalTrials.gov registry entry for NCT04557618 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The listed sponsor is Anna Huguenard, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Auricular Vagus Nerve Stimulation is the first listed.

NCT04557618 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04557618 about?

NCT04557618 is a clinical study titled "Auricular VNS Following Subarachnoid Hemorrhage". This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.

What is the current status of trial NCT04557618?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-01-05. Estimated completion is 2028-12.

What conditions does trial NCT04557618 study?

This clinical trial studies the following conditions: Subarachnoid Hemorrhage.

What interventions are being tested in trial NCT04557618?

The interventions under investigation include: Auricular Vagus Nerve Stimulation (DEVICE), Sham Auricular Vagus nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04557618?

This trial is sponsored by Anna Huguenard, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04557618 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Subarachnoid Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.